ATE544462T1 - Verwendung des epidermalen wachstumsfaktors zur morphofunktionellen wiederherstellung von peripheren nerven bei diabetischer neuropathie - Google Patents

Verwendung des epidermalen wachstumsfaktors zur morphofunktionellen wiederherstellung von peripheren nerven bei diabetischer neuropathie

Info

Publication number
ATE544462T1
ATE544462T1 AT07817382T AT07817382T ATE544462T1 AT E544462 T1 ATE544462 T1 AT E544462T1 AT 07817382 T AT07817382 T AT 07817382T AT 07817382 T AT07817382 T AT 07817382T AT E544462 T1 ATE544462 T1 AT E544462T1
Authority
AT
Austria
Prior art keywords
growth factor
epidermal growth
diabetic neuropathy
peripheral nerves
morphofunctional
Prior art date
Application number
AT07817382T
Other languages
English (en)
Inventor
Montequoen Jose Fernandez
Martinez Luis Herrera
Acosta Jorge Berlanga
Del Barco Herrera Diana Garcia
Vera Danay Cibrian
Nieto Gerardo Guillen
Gamez Raimundo Ubieta
Blanco Sonia Gonzalez
Martoenez Vivian Maria Saez
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38925545&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE544462(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Application granted granted Critical
Publication of ATE544462T1 publication Critical patent/ATE544462T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT07817382T 2006-10-03 2007-10-01 Verwendung des epidermalen wachstumsfaktors zur morphofunktionellen wiederherstellung von peripheren nerven bei diabetischer neuropathie ATE544462T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20060192A CU23526B6 (es) 2006-10-03 2006-10-03 Método para la restauración morfofuncional de nervios periféricos en la neuropatía diabética
PCT/CU2007/000018 WO2008040260A1 (es) 2006-10-03 2007-10-01 Uso del factor de crecimiento epidérmico para la restauración morfofuncional de nervios periféricos en la neuropatía diabética

Publications (1)

Publication Number Publication Date
ATE544462T1 true ATE544462T1 (de) 2012-02-15

Family

ID=38925545

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07817382T ATE544462T1 (de) 2006-10-03 2007-10-01 Verwendung des epidermalen wachstumsfaktors zur morphofunktionellen wiederherstellung von peripheren nerven bei diabetischer neuropathie

Country Status (20)

Country Link
US (2) US8642552B2 (de)
EP (1) EP2075004B1 (de)
JP (1) JP5508853B2 (de)
KR (1) KR101464208B1 (de)
CN (1) CN101573130B (de)
AR (1) AR063088A1 (de)
AT (1) ATE544462T1 (de)
AU (1) AU2007304640B2 (de)
BR (1) BRPI0719816B8 (de)
CA (1) CA2665117C (de)
CL (1) CL2007002862A1 (de)
CU (1) CU23526B6 (de)
DK (1) DK2075004T3 (de)
ES (1) ES2386058T3 (de)
MX (1) MX2009003678A (de)
PL (1) PL2075004T3 (de)
PT (1) PT2075004E (de)
RU (1) RU2460536C2 (de)
WO (1) WO2008040260A1 (de)
ZA (1) ZA200902311B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101252740B1 (ko) * 2011-05-25 2013-04-11 연세대학교 산학협력단 센서 및 센싱방법
EP2737895A1 (de) * 2012-11-30 2014-06-04 Praxis Pharmaceutical, S.A. Mikropartikel mit EGF, Herstellungsverfahren und Verwendung
KR102228358B1 (ko) * 2012-12-21 2021-03-16 쉬케후세트 솔란데트 에이치에프 신경 장애 및 통증의 ｅｇｆｒ 표적 치료
CA2920835A1 (en) 2013-08-20 2015-02-26 Anutra Medical, Inc. Syringe fill system and method
IL312865B2 (en) * 2013-09-11 2025-06-01 Eagle Biologics Inc Liquid protein formulations containing viscosity-lowering agents
USD774182S1 (en) 2014-06-06 2016-12-13 Anutra Medical, Inc. Anesthetic delivery device
USD750768S1 (en) 2014-06-06 2016-03-01 Anutra Medical, Inc. Fluid administration syringe
USD763433S1 (en) 2014-06-06 2016-08-09 Anutra Medical, Inc. Delivery system cassette
SG11201702614SA (en) 2014-10-01 2017-04-27 Eagle Biolog Inc Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
RU2585421C1 (ru) * 2014-12-24 2016-05-27 Артур Владимирович Маргасов Способ восстановления поврежденного нерва

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
SE9601243D0 (sv) * 1996-03-29 1996-03-29 Hans Arne Hansson Promotion of regeneration of organized tissues
AU2231399A (en) 1998-01-20 1999-08-02 Aurx, Inc. A herpes virus vector
US6444205B2 (en) 1998-09-30 2002-09-03 Diacrin, Inc. Transplantation of neural cells for the treatment of chronic pain or spasticity
SE9804064D0 (sv) 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
CA2365434A1 (en) * 1999-04-15 2000-10-26 St. Elizabeth's Medical Center Of Boston Angiogenic growth factors for treatment of peripheral neuropathy
AU2001281254A1 (en) 2000-08-10 2002-02-18 Pharmacia Corporation A new egf motif repeat protein obtained from a cdna library from hs-5 stromal cell line
CU23157A1 (es) 2001-01-03 2006-07-18 Ct Ingenieria Genetica Biotech COMPOSICION FARMACéUTICA PARA EL TRATAMIENTO DEL DANO TISULAR DEBIDO A FALTA DE IRRIGACION SANGUINEA ARTERIAL
JP2006152001A (ja) 2001-03-12 2006-06-15 Institute Of Gene & Brain Science 神経損傷の治療薬
JP3607271B2 (ja) 2001-03-12 2005-01-05 株式会社Ｇｂｓ研究所 神経損傷の治療薬
CU23043A1 (es) * 2001-12-20 2005-05-20 Ct Ingenieria Genetica Biotech Composicion farmaceutica que contiene factor de crecimiento epidrmico (egf) para la prevencion de la amputacion de pie diabetico.
US7465463B2 (en) 2002-09-04 2008-12-16 Polyheal, Ltd. Compositions comprising microspheres with anti-inflammatory properties for healing of ocular tissues
WO2004084819A2 (en) * 2003-03-19 2004-10-07 University Of Kentucky Research Foundation Poly(acryloyl-hydroxyethyl starch)-plga composite microspheres
ATE482713T1 (de) * 2003-04-25 2010-10-15 Univ Pittsburgh Von muskeln stammende zellen (mdcs) zur förderung und verbesserung der nervenreparatur und - regeneration
WO2006012707A1 (en) 2004-08-06 2006-02-09 Gropep Limited Method for treating diabetes
MX2007008826A (es) 2005-01-21 2007-11-15 Univ Northwestern Metodos y composiciones para encapsulacion de celulas.
KR100765496B1 (ko) 2005-12-09 2007-10-10 경희대학교 산학협력단 히레귤린 베타1의 ｅｇｆ-성 도메인 펩타이드를 암호화하는ｄｎａ 서열을 포함하는 재조합 아데노바이러스 및 이를포함하는 신경세포 분화 및 재생용 약학 조성물

Also Published As

Publication number Publication date
US20140105990A1 (en) 2014-04-17
WO2008040260A1 (es) 2008-04-10
CN101573130B (zh) 2012-10-31
JP5508853B2 (ja) 2014-06-04
KR101464208B1 (ko) 2014-12-04
EP2075004B1 (de) 2012-02-08
BRPI0719816B1 (pt) 2018-04-24
ZA200902311B (en) 2010-04-28
AU2007304640A1 (en) 2008-04-10
DK2075004T3 (da) 2012-05-14
PL2075004T3 (pl) 2012-09-28
RU2460536C2 (ru) 2012-09-10
KR20090103862A (ko) 2009-10-01
MX2009003678A (es) 2009-04-22
CA2665117A1 (en) 2008-04-10
PT2075004E (pt) 2012-05-02
US8642552B2 (en) 2014-02-04
CU23526B6 (es) 2010-05-19
CN101573130A (zh) 2009-11-04
CL2007002862A1 (es) 2008-05-23
US20100136062A1 (en) 2010-06-03
RU2009116646A (ru) 2010-11-10
ES2386058T3 (es) 2012-08-08
BRPI0719816A2 (pt) 2015-09-08
BRPI0719816B8 (pt) 2021-05-25
EP2075004A1 (de) 2009-07-01
AR063088A1 (es) 2008-12-23
AU2007304640B2 (en) 2013-01-17
US9034826B2 (en) 2015-05-19
JP2010505773A (ja) 2010-02-25
CA2665117C (en) 2015-04-14

Similar Documents

Publication Publication Date Title
EP1948799A4 (de) Verwendung von bakteriocinen zur förderung von pflanzenwachstum und krankheitsresistenz
DE602007001869D1 (de) Verwendung von haarpflegezusammensetzungen zur konditionierung gebleichter haare
ZA200902311B (en) Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy
DE602005022859D1 (de) Heteroarylbenzamidderivate zur verwendung als glk-aktivatoren bei der behandlung von diabetes
EP2297182A4 (de) Supergeladene proteine zur zellpenetration
EP2060040A4 (de) Verwendung von satztokens in transaktionen
DE602005025340D1 (de) Chimäre adenoviren zur verwendung in der krebsbehandlung
EP2103212A4 (de) Pflanzenwachstumsregulator und seine verwendung
EP2282724A4 (de) Modifizierte wirkstoffe zur verwendung in liposomalen nanopartikeln
EP2139337A4 (de) Hemmstoffe des fibroblastenaktivierungsproteins und verfahren zu ihrer verwendung
EP2271818A4 (de) Bremsvorrichtungen und -verfahren zur verwendung in bohroperationen
DE602007011052D1 (de) Behandlung von mineralschlämmen mit verbesserter pflanzenwachstumsrehabilitation
ATE495179T1 (de) Tetrahydropyridothienpyrimidin-verbindungen und verwendung zur behandlung proliferativer erkrankungen
EP2376106A4 (de) Knochentransplantate mit verringerter proteasewirkung und auswahl- und anwendungsverfahren
EP2439275A4 (de) Gen zur erhöhung des proteingehalts in samen sowie verfahren zu seiner verwendung
EP2350013A4 (de) Zusammensetzungen zur markierung und identifizierung von autophagosomen sowie verfahren zu ihrer herstellung und verwendung
EP2039757A4 (de) Verfahren zur zell- oder gewebekultivierung
EP1814394A4 (de) Verwendung von antioxidationsmitteln zur genmodulation
EP2091530A4 (de) Zusammensetzung zur hemmung von nadph-oxidaseaktivität
ATE516295T1 (de) Chimäre promotoren zur verwendung in pflanzen
DE602006010400D1 (de) Olanzapin-analoga und verfahren zu ihrer verwendung
IL203762A (en) Use of collagen-containing preparation for biological cell growth
AT505253A3 (de) Bauelemente unter verwendung von natursteinen und verfahren zur herstellung
DE602008003483D1 (de) Werkzeugausrichtungsbefestigung und Methode zur Verwendung
EP2305644A4 (de) Aralkylalkoholpiperidinderivate und dessen verwendung als medikament zur behandlung von depression